Quantitative determination of paclitaxel in human plasma using semi-automated liquid-liquid extraction in conjunction with liquid chromatography/tandem mass spectrometry

被引:43
作者
Basileo, G [1 ]
Breda, M [1 ]
Fonte, G [1 ]
Pisano, R [1 ]
James, CA [1 ]
机构
[1] Pharmacia SPA, Global Drug Metab, I-20014 Milan, Italy
关键词
paclitaxel; semi-automated liquid-liquid extraction; LC-MS; human plasma;
D O I
10.1016/S0731-7085(03)00166-3
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
This paper describes a high-throughput sample preparation procedure combined with LC-MS/MS analysis to measure paclitaxel in human plasma. Paclitaxel and an internal standard were extracted from plasma by a semi-automated robotic method using liquid-liquid extraction. Thereafter compounds were separated on a RP C18 column. Detection was by a PE Sciex API 3000 mass spectrometer equipped with a TurbolonSpray(TM) interface. The compounds were detected in positive ion mode using the mass transition m/z 854.6-->286.2 and m/z 831.6-->263.2 for paclitaxel and the internal standard, respectively. The limit of quantitation for paclitaxel was 1 ng/ml with an imprecision of 5.2% following extraction of 0.1 ml of plasma. Linearity was confirmed over the whole calibration range (1-1000 ng/ml) with correlation coefficients higher than 0.99 indicating good fits of the regression models. The inter and intra-day precision was better than 9.5% and the accuracy ranged from 90.3 to 104.4%. The assay was simple, fast, specific and exhibited excellent ruggedness. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:591 / 600
页数:10
相关论文
共 34 条
[1]  
BITCH F, 1993, J CHROMATOGR, V615, P273
[2]   EXPEDIENT LIQUID-CHROMATOGRAPHIC ASSAY FOR PACLITAXEL IN PLASMA AFTER ITS ADMINISTRATION TO CANCER-PATIENTS [J].
ELYAZIGI, A ;
YUSUF, A .
THERAPEUTIC DRUG MONITORING, 1995, 17 (05) :511-515
[3]  
GREM JL, 1987, CANCER TREAT REP, V71, P1179
[4]   AN ENZYME-IMMUNOASSAY FOR THE DETERMINATION OF TAXOL AND TAXANES IN TAXUS SP TISSUES AND HUMAN PLASMA [J].
GROTHAUS, PG ;
RAYBOULD, TJG ;
BIGNAMI, GS ;
LAZO, CB ;
BYRNES, JB .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 158 (01) :5-15
[5]   Determination of paclitaxel in biological fluids by micellar electrokinetic chromatography [J].
Hempel, G ;
Lehmkuhl, D ;
Krumpelmann, S ;
Blaschke, G ;
Boos, J .
JOURNAL OF CHROMATOGRAPHY A, 1996, 745 (1-2) :173-179
[6]   PHASE-II TRIAL OF TAXOL, AN ACTIVE-DRUG IN THE TREATMENT OF METASTATIC BREAST-CANCER [J].
HOLMES, FA ;
WALTERS, RS ;
THERIAULT, RL ;
FORMAN, AD ;
NEWTON, LK ;
RABER, MN ;
BUZDAR, AU ;
FRYE, DK ;
HORTOBAGYI, GN .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (24) :1797-1805
[7]   Quantification of paclitaxel metabolites in human plasma by high-performance liquid chromatography [J].
Huizing, MT ;
Sparreboom, A ;
Rosing, H ;
vanTellingen, O ;
Pinedo, HM ;
Beijnen, JH .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 674 (02) :261-268
[8]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC PROCEDURES FOR THE QUANTITATIVE-DETERMINATION OF PACLITAXEL (TAXOL) IN HUMAN URINE [J].
HUIZING, MT ;
ROSING, H ;
KOOPMAN, F ;
KEUNG, ACF ;
PINEDO, HM ;
BEIJNEN, JH .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 664 (02) :373-382
[9]   STEADY-STATE PLASMA-CONCENTRATIONS AND EFFECTS OF TAXOL FOR A 250-MG/M(2) DOSE IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH OVARIAN-CANCER [J].
JAMISDOW, CA ;
KLECKER, RW ;
SAROSY, G ;
REED, E ;
COLLINS, JM .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 33 (01) :48-52
[10]   PACLITAXEL (TAXOL) [J].
KOHLER, DR ;
GOLDSPIEL, BR .
PHARMACOTHERAPY, 1994, 14 (01) :3-34